CD95 predicts responsiveness to tretinoin in acute promyelocytic leukemia.

  • Authors:
    • H Tomizuka
    • K Hatake
    • M Ikeda
    • Y Gunji
    • K Ikeda
    • T Takizawa
    • T Saito
    • Y Hoshino
    • T Ohtsuki
    • H Takahashi
    • S Yonehara
    • Y Miura
  • View Affiliations

  • Published online on: January 1, 1998     https://doi.org/10.3892/ijmm.1.1.207
  • Pages: 207-218
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

We describe a predictive marker (CD95) for the responsiveness to tretinoin (RA) in acute promyelocytic leukemia (APL). Functional CD95 expression during RA treatment have been observed only in those patients who responded to RA. Expression of CD95 (Fas antigen), which plays a major role in apoptosis, was determined by fluorescence activated cell sorter (FACS) analysis. APL cases in which no enhancement of CD95 expression was observed showed no response to RA and did not obtain complete remission. We propose that CD95 can predict the clinical response to RA probably due to differentiation.

Related Articles

Journal Cover

Jan 1998
Volume 1 Issue 1

Print ISSN: 1107-3756
Online ISSN:1791-244X

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Tomizuka H, Hatake K, Ikeda M, Gunji Y, Ikeda K, Takizawa T, Saito T, Hoshino Y, Ohtsuki T, Takahashi H, Takahashi H, et al: CD95 predicts responsiveness to tretinoin in acute promyelocytic leukemia.. Int J Mol Med 1: 207-218, 1998
APA
Tomizuka, H., Hatake, K., Ikeda, M., Gunji, Y., Ikeda, K., Takizawa, T. ... Miura, Y. (1998). CD95 predicts responsiveness to tretinoin in acute promyelocytic leukemia.. International Journal of Molecular Medicine, 1, 207-218. https://doi.org/10.3892/ijmm.1.1.207
MLA
Tomizuka, H., Hatake, K., Ikeda, M., Gunji, Y., Ikeda, K., Takizawa, T., Saito, T., Hoshino, Y., Ohtsuki, T., Takahashi, H., Yonehara, S., Miura, Y."CD95 predicts responsiveness to tretinoin in acute promyelocytic leukemia.". International Journal of Molecular Medicine 1.1 (1998): 207-218.
Chicago
Tomizuka, H., Hatake, K., Ikeda, M., Gunji, Y., Ikeda, K., Takizawa, T., Saito, T., Hoshino, Y., Ohtsuki, T., Takahashi, H., Yonehara, S., Miura, Y."CD95 predicts responsiveness to tretinoin in acute promyelocytic leukemia.". International Journal of Molecular Medicine 1, no. 1 (1998): 207-218. https://doi.org/10.3892/ijmm.1.1.207